Testicular cancer and molecular genetics.
Giwercman
A
A
Fertility Centre, Department of Urology and Department of Clinical Chemistry, Malmö University Hospital, Lund University, Malmö, Sweden.
Dezuýei
N
N
Lundwall
A
A
Bjartell
A
A
Giwercman
Y L
YL
D000328:Adult; D002278:Carcinoma in Situ / Q000235:genetics / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000473:pathology; D004268:DNA-Binding Proteins / Q000235:genetics; D020022:Genetic Predisposition to Disease; D018237:Germinoma / Q000235:genetics* / Q000473:pathology; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D008297:Male; D009154:Mutation; D000071317:Nanog Homeobox Protein; D050814:Octamer Transcription Factor-3 / Q000235:genetics; D011944:Receptors, Androgen / Q000235:genetics / Q000502:physiology; D013736:Testicular Neoplasms / Q000235:genetics* / Q000473:pathology
D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; C486780:NANOG protein, human; D000071317:Nanog Homeobox Protein; D050814:Octamer Transcription Factor-3; C494173:POU5F1 protein, human; D011944:Receptors, Androgen